SCHEMBL7226014

SCHEMBL7226014

COc1cccc(Oc2ccc(C(=O)N[C@@H]3C[C@H]4CC[C@@H]3N4)s2)c1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.41
SLC6A4 P31645 4/20 0.41
SLC6A3 Q01959 4/20 0.41
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
HTR4 Q13639 1/20 0.37
GRM5 P41594 1/20 0.37
ALDH1A1 P00352 1/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
CHRNA7 P36544 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231868 0.90 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3
SCHEMBL7225149 0.90 HTR4 (0.37) SLC6A2SLC6A4SLC6A3HTR4ALDH1A1
SCHEMBL7223531 0.89 CHRNB4 (0.40) SLC6A2SLC6A4SLC6A3NPC1POLB
SCHEMBL7232389 0.89 NPC1 (0.36) SLC6A2SLC6A4SLC6A3GRM5ALDH1A1
SCHEMBL7225045 0.88 SLC6A3 (0.41) SLC6A2SLC6A4SLC6A3GRM5
SCHEMBL7231813 0.88 CHRNA7 (0.34) SLC6A2SLC6A4SLC6A3CHRNA7
SCHEMBL7225381 0.88 HTR3E (0.37) SLC6A2SLC6A4SLC6A3NPC1CHRNA7
SCHEMBL7225732 0.87 SMN1; SMN2 (0.36) MTNR1AMTNR1BALDH1A1NPC1RAB9A
SCHEMBL7230406 0.87 PARP14 (0.38) NPC1OPRM1OPRD1
SCHEMBL7234424 0.86 F2 (0.35) SLC6A2SLC6A4SLC6A3ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed